The ATM-dependent DNA Damage Signaling Pathway

  1. R. KITAGAWA* and
  2. M.B. KASTAN
  1. Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
  2. *Present address: Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 322 N. Lauderdale Street, Memphis, Tennessee 38105.

Abstract

Many of the insights that we have gained into the mechanisms involved in cellular DNA damage response pathways havecome from studies of human cancer susceptibility syndromes that are altered in DNA damage responses. ATM, the gene mutatedin the disorder, ataxia-telangiectasia, is a protein kinase that is a central mediator of responses to DNA double-strandbreaks in cells. Recent studies have elucidated the mechanism by which DNA damage activates the ATM kinase and initiatesthese critical cellular signaling pathways. The SMC1 protein appears to be a particularly important target of the ATMkinase, playing critical roles in controlling DNA replication forks and DNA repair after the damage. A major role for theNBS1 and BRCA1 proteins appears to be in the recruitment of an activated ATM kinase molecule to the sites of DNA breaksso that ATM can phosphorylate SMC1. Generation of mice and cells that are unable to phosphorylate SMC1 demonstratedthe importance of SMC1 phosphorylation in the DNA-damage-induced S-phase checkpoint, in determining rates of repair ofchromosomal breaks, and in determining cell survival after DNA damage. Focusing on ATM and SMC1, the molecular controlsof these pathways is discussed.

Footnotes

| Table of Contents